focus -WSS

focus

author：Wikipedia 2025-09-06 04:17:49 - browse：11

Adobe

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient its business around selling its products directly to users over the counter, rather than by prescription.

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. The Boston-based company will continue offering its pediatric treatment, EndeavorRx, by prescription until it can convert it to over-the-counter labeling — it plans to submit data to FDA in 2024.

Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues. In its second-quarter results reported in August, Akili said it earned just $114,000 on $15.3 million in expenses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Dozens dead from Maui wildfires: What we know about the victims

leisure time

entertainment

WSS

Aspartame and sugar

Illumina slashes 2023 revenue projections yet again

After Optum profits sink, UnitedHealth makes changes

Patients, digital health players weigh in on FTC's data privacy plan

Surge in Apellis stock fueled by confidence in safety of its eye drug

Montana youths win climate lawsuit against state for promoting fossil fuels

leisure time

focus

leisure time

In age of alternative facts, a scholarly course on calling out crap

Illinois Supreme Court finds assault weapons ban constitutional

23andMe had bad news about my health. I wish a person had delivered it

Patients, digital health players weigh in on FTC's data privacy plan

Apple is now the first public company to be valued at $3 trillion

Dozens dead from Maui wildfires: What we know about the victims

As demand for Covid shots wanes, Moderna seeks its next success

Mark Cuban is blaming the wrong people for high drug costs

Anesthesiologist group: stop taking Ozempic before surgery

Be careful with at

hotspot

Illumina slashes 2023 revenue projections yet again

Surge in Apellis stock fueled by confidence in safety of its eye drug

Dozens dead from Maui wildfires: What we know about the victims

Aspartame and sugar

Bird flu researchers hone in on Finland’s mink farms

After Optum profits sink, UnitedHealth makes changes

Wikipedia

leisure time

entertainment

focus